- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hormone-resistant Prostate Cancer in United States
Total 7270 results
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Prostate Cancer Foundation; Madison Vaccines, IncActive, not recruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
Duke UniversityCompleted
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate Cancer DiseaseUnited States
-
AbbVieRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Israel
-
CelgeneCompletedHormone Refractory Prostate CancerUnited States
-
Tavanta TherapeuticsCompletedMetastatic Prostate Cancer | Metastatic Castration-sensitive Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Hungary, France, Poland, Puerto Rico, Sweden
-
Lava TherapeuticsMerck Sharp & Dohme LLCRecruitingMetastatic Castration Resistant Prostate CancerUnited States, Spain, Netherlands
-
Novo Nordisk A/STerminated
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
Bristol-Myers SquibbRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Prostate | Hormonal CyclingUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustSheffield Hallam UniversityUnknownProstate Cancer | Prostatic Neoplasms, Castration-ResistantUnited Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone Refractory Prostate CancerUnited States, Canada
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate CancerUnited States
-
Eli Lilly and CompanyCompletedMetastatic Castration-Resistant Prostate CancerFrance, United States, Spain
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate Cancer (CRPC)United States, Moldova, Republic of, South Africa
-
University of WashingtonNational Cancer Institute (NCI)TerminatedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IV Prostate Cancer AJCC v7United States
-
AstraZenecaCompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Immunic AGTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Veru Inc.TerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
Coherus Biosciences, Inc.Arcus Biosciences, Inc.; Surface OncologyTerminatedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Canada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of DefenseRecruitingCastration Resistant Metastatic Prostate CancerUnited States
-
Peng Wang, MD PhDWithdrawnMetastatic Hormone-Sensitive Prostate CancerUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedMultiple Myeloma | Recurrent Prostate Cancer | Plasmacytoma | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)UnknownCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Metastatic Hormone-sensitive Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
Institute of Cancer Research, United KingdomAstraZeneca; Astellas Pharma Inc; Prostate Cancer UKTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Washington University School of MedicineBristol-Myers Squibb; The Foundation for Barnes-Jewish Hospital; Bavarian Nordic and other collaboratorsCompletedMetastatic Hormone-Sensitive Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Merrion Pharmaceuticals, LLCCompletedHormone-Refractory Prostate CancerUnited States, Estonia, Latvia
-
Taiho Oncology, Inc.Active, not recruitingMetastatic Castration Resistant Prostate CancerFrance, United States, Spain, United Kingdom
-
Roswell Park Cancer InstituteWithdrawnCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the Bone | PSA...United States
-
zr Pharma & GmbHCompletedMetastatic Castration Resistant Prostate CancerUnited States
-
Roswell Park Cancer InstituteAbbVieCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Castration Levels of Testosterone | Prostate Carcinoma...United States
-
Institute of Cancer Research, United KingdomSun Pharmaceutical Industries LimitedTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
Laekna LimitedActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Korea, Republic of
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of MiamiRecruitingProstate Cancer | Prostate Adenocarcinoma | Hormone Sensitive Prostate CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterPatient-Centered Outcomes Research InstituteCompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of ProstateUnited States
-
OHSU Knight Cancer InstituteUnited States Department of Defense; Oregon Health and Science UniversityCompletedCastration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | PSA Progression | Castration Levels of TestosteroneUnited States
-
National Cancer Institute (NCI)SuspendedCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States